Multidrug Resistance in Acute Leukemia: A Conserved Physiologic Function

References

• Second International Workshop on Chromosomes in Leukemia and Preleukemia. Cancer Genet. Cytogenet. 1979; 2: 108–113
   Google Scholar
• Bloomfield C. D., De La Chapelle A. Chromosome abnormalities in acute nonlymphocytic leukemia: Clinical and biological significance. Semin. One 1987; 14: 372–383
   PubMed Web of Science ®Google Scholar
• Fourth International Workshop on Chromosomes in Leukemia. Correlation of karyotype and occupational exposure to potential mutagenic/carcinogenic agents in acute nonlymphocytic leukemia. Cancer Genet. Cytogenet. 1982; 11: 326–332
   Google Scholar
• Geller R. B., Zahurak M., Hurwitz C. A., et al. Prognostic importance of immunophenotyping in adults with acute myelocytic leukemia: The significance of the stem-cell glycoprotein CD34 (MylO). Br. J. Haematol 1990; 76: 340–347
   PubMed Web of Science ®Google Scholar
• Amadori S., Pett M. C., De Francesco A., et al. Lack of prognostic significance of the pretreatment labelling and mitotic indices of marrow blasts in acute nonlymphocytic leukemia (ANLL). Cancer, 41: 1154–1160
   PubMed Web of Science ®Google Scholar
• Maddox A. M., Johnston D. A., Barlogie B., Youness E., Keating M., Freireich E. J. DNA-RNA measurements in patients with acute leukemia undergoing remission induction therapy. J. Clin. Oncol 1985; 3: 799–808
   PubMed Web of Science ®Google Scholar
• Pastan I., Gottesman M. Multidrug resistance in human cancer. N. Engl. J. Med 1979; 316: 1388–1393
   Google Scholar
• Gros P., Ben-Neriah Y., Croop J., Housman D. E. Isolation and expression of a cDNA (mdr) that confers multidrug resistance. Nature 1986; 323: 728–731
   PubMed Web of Science ®Google Scholar
• Ueda K., Cardalelli C., Gottesman M. M., Pastan I. Expression of a full-length cDNA for the human mdr 1 gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc. Natl. Acad. Sci. USA 1987; 84: 3004–3008
   PubMed Web of Science ®Google Scholar
• Callan D. F., Baker E., Simmers R. N., Seshardri R., Roninson I. B. Localization of the human multiple drug resistance gene, mdr 1, to 7q21.1. Human Genet. 1987; 77: 142–144
   PubMed Web of Science ®Google Scholar
• Weinstein R. S., Kuszak J. R., Kluskens L. F., et al. P-glycoproteins in pathology: The multidrug resistance gene family in humans. Human Path. 1990; 21: 34–48
   PubMed Web of Science ®Google Scholar
• Raymond M., Rose E., Houseman D. E., Gros P. Physical mapping, amplification, and overexpression of the mouse MDR gene family in multidrug-resistant cells. Mol Cell Biol 1990; 10: 1642–1651
   PubMed Web of Science ®Google Scholar
• Herweijer H., Sonneveld P., Baas F., Nooter K. Expression of mdr 1, mdr 3 and multidrug-resistance genes in human acute and chronic leukemias in association with stimulation of drug accumulation by cyclosporine. JNCI 1990; 82: 1133–1140
   PubMed Web of Science ®Google Scholar
• Thiebaut F., Tsuruo T., Hamada H., Gottesman M. M., Pastan I., Willingham N. C. Cellular localization of the multidrug resistance gene product P-glycoprotein in normal human tissues. Proc. Nat. Acad. Sci. USA 1987; 84: 7735–7738
   PubMed Web of Science ®Google Scholar
• Cordon-Cardo C., O'Brien J. P., Boccia J., Casals D., Bertino J. R., Melamed M. R. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal tumor tissues. J. Histochem. Cytochem. 1990; 38: 1277–1278
   PubMed Web of Science ®Google Scholar
• Cordon-Cardo C., O'Brien J. P., Casals D., et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at the blood-brain barrier sites. Proc. Natl Acad. Sci. USA 1989; 86: 695–698
   PubMed Web of Science ®Google Scholar
• Arceci R. J., Croop J. M., Horwitz S. B., Housman D. E. The gene encoding multidrug resistance is induced and expressed at high levels during preganancy in the secretory epithelium of the uterus. Proc. Natl Acad. Sci. USA 1988; 85: 435CM354
   Web of Science ®Google Scholar
• Gosland M. P., Brophy N. A., Duran G. E., Yahanda A. M., et al. Bilirubin: A physiologic substrate for the multidrug transporter. Proc. Am. Assn. Cancer Res. 1991; 32: 426A
   Google Scholar
• Yang C.-C. P., De Pinho S. G., Greenberger L. M., et al. Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus. J. Biol Chem. 1989; 264: 782–788
   PubMed Web of Science ®Google Scholar
• Fojo A. T., Ueda K., Slamon P. J., et al. Expression of a multidrug resistance gene in human tumors and tissues. Proc. Natl Acad. Sci. USA 1987; 84: 265–269
   PubMed Web of Science ®Google Scholar
• Mickley L. A., Bates S. E., Richert N. D., et al. Modulation of the expression of a multidrug resistance gene (mrfr-1/P-glycoprotein) by differentiating agents. J. Biol Chem. 1989; 264: 18031–18040
   PubMed Web of Science ®Google Scholar
• Fine R. L., Koizumi S., Curt G. A., Chabner B. A. Effective calcium channel blockers on human CFU-GM with cytotoxic drugs. J. Clin. Oncol 1987; 5: 489–495
   PubMed Web of Science ®Google Scholar
• Smith A. S., Smith J. G., Merry S., Kaye S. B. Clinically achievable concentrations of verapamil do not enhance the sensitivity of human marrow CFU-GM to doxorubicin or etoposide. Br. J. Haematol 1988; 69(suppl 1)131A
   Web of Science ®Google Scholar
• Nakarai T., Koizumi S. Effects of calcium antagonists on anticancer drug toxicity to haematopoietic progenitor cells in normal human bone marrow. Leuk. Res. 1990; 14: 401–405
   PubMed Web of Science ®Google Scholar
• Chao N. J., Aihara M., Blume K. G., Sikic B. I. Modulation of etoposide (VP-16): Cytotoxicity by verapamil or cyclosporine in multidrug-resistant human leukemic cell lines and normal bone marrow. Exper. Hematol 1990; 18: 1193–1198
   PubMed Web of Science ®Google Scholar
• Marie J.-P., Brophy N. A., Ehsan M. N., Chao N. J., Sikic B. I. Expression of the multidrug resistance gene (mdr 1) detected by RNA phenotyping and in situ RNA hybridization in bone marrow cells. Proc. Am. Assn. Cancer Res. 1990; 31: 371
   Google Scholar
• Ploemacher R. E., Brons N. H. C. Cells with marrow and spleen repopulating ability in forming spleen colonies on Days 16, 12, and 8 are sequentially ordered on the basis of increasing rhodamine-123 retention. J. Cell Physiol 1988; 136: 531–536
   PubMed Web of Science ®Google Scholar
• Wall D. M., Hu X. F., Zalcberg J. R., Parkin J. D. Rapid functional assay for multidrug resistance in human tumor cell lines using the fluorescent indicator Fluo-3. JNCI 1991; 83: 206–207
   PubMed Web of Science ®Google Scholar
• Kessel D., Beck W. T., Kukuruga D., Schulz V. Characterization of multidrug resistance by fluorescent dyes. Cancer Res. 1991; 51: 4665–4670
   PubMed Web of Science ®Google Scholar
• List A. F., Spier C. M., Cline A., et al. Expression of the multidrug resistance gene product (P-glycoprotein) in myelodysplasia is associated with the stem cell phenotype. Br. J. Haematol 1991; 78: 28–34
   PubMed Web of Science ®Google Scholar
• List A. F., Glinsmann-Gibson B. Multidrug resistance and its pharmacologic modulation in acute myeloid leukemia. Accomplishments in Cancer Research;, G. Foster Joseph, E. Rhodes Jonathan. J. B. Lippincott, Publishers 1992; 178–183
   Google Scholar
• Spier C. M., List A. F., Willman C., et al. Multidrug resistance (MDR) in CD34+ acute leukemia correlates with nonlymphoid lineage. Blood 1991; 78(suppl 1)46A
   Google Scholar
• Futscher B. W., Blake L. L., Grogan T. M., Dalton W. S. Quantitative PCR analysis of mdr 1 mRNA in patients with multiple myeloma. Proc. Am. Assn. Cancer Res. 1992; 33: 467a
   Google Scholar
• Georges E., Bradley G., Gariepy J., Ling V. Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies. Proc. Natl. Acad. Sci. USA 1990; 87: 152–156
   PubMed Web of Science ®Google Scholar
• Schinkel A. H., Roellfs M. E. M., Borst P. Characterization of the human mdr 1 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies. Cancer Res. 1991; 51: 2628–2635
   PubMed Web of Science ®Google Scholar
• Pirker R., Wallner J., Geissler K., et al. MDR1 gene expression and treatment outcome in acute myeloid leukemia. JNCI 1991; 83: 708–712
   PubMed Web of Science ®Google Scholar
• Campos L., Guyotat D., Archimbaud E., et al. Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood 1992; 79: 473–476
   PubMed Web of Science ®Google Scholar
• Willman C. L., Kopecky K., Griffith B., et al. Multiparameter analysis of the expression of the multidrug resistance genes mdr 1, mdr 2 (mdr 2) in de novo AML by polymerase chain reaction in multicolor flow cytometry: identification of a biological subset of CD34+, mdr 1 + AML cases. Blood 1991; 78(suppl 1)172A
   Google Scholar
• Chaudhary P. M., Roninson I. B. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 1991; 66: 85–94
   PubMed Web of Science ®Google Scholar
• Schlaifer B., Laurent G., Chittal S., et al. Immunohistochemical detection of multidrug resistance associated with P-glycoprotein in tumour and stromal cells of human cancers. Br. J. Cancer 1990; 62: 177–182
   PubMed Web of Science ®Google Scholar
• Holmes J. A., Jacobs A., Carter G., Whittaker J. A., Bentley D. P., Padua R. A. Is the mdr 1 gene relevant in chronic lymphocytic leukemia?. Leukemia 1990; 4: 216–218
   PubMed Web of Science ®Google Scholar
• Borowitz M. J., Shuster J. J., Civin C. I., et al. Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: A pediatric oncology group study. J. Clin. Oncol 1990; 8: 1389–1398
   PubMed Web of Science ®Google Scholar
• Goldstein L. J., Galsi H., Fojo A., et al. Expression of multidrug-resistant gene in human tumors. JNCI 1989; 81: 116–124
   PubMed Web of Science ®Google Scholar
• Rothenberg M. L., Mickley L. A., Cole D. E., et al. Expression of the mdr 1/P-110 gene in patients with acute lymphoblastic leukemia. Blood 1989; 1974: 1388–1395
   Google Scholar
• Kuwazuru Y., Hanada S., Furukawa T., et al. Expression of P-glycoprotein in adult T-cell leukemia cells. Blood 1990; 76: 2065–2071
   PubMed Web of Science ®Google Scholar
• Neyfakh A. A., Serpinskaya A. S., Chervonsky A. V., Apasov S. G., Kazarov A. R. Multidrug-resistance phenotype of subpopulation of T-lymphocytes without drug selection. Exper. Cell Res. 1989; 185: 496–505
   PubMed Web of Science ®Google Scholar
• Coon J. S., Wang Y., Bines S. D., et al. Multidrug resistance activity in human lymphocytes. Hum. Immunol 1991; 32: 134–140
   PubMed Web of Science ®Google Scholar
• Riordan J. R., Rommens J. M., Kerem B., et al. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 1989; 245: 1066–1073
   PubMed Web of Science ®Google Scholar
• Gros P., Croop J., Housman D. Mammalian multidrug resistance gene: Complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 1986; 47: 371–380
   PubMed Web of Science ®Google Scholar
• Deverson E. V., Gow I. R., Coadwell W. J., et al. MHC Class II region encoding proteins related to the multidrug resistance family of transmembrane transporters. Nature 1990; 348: 738–741
   PubMed Web of Science ®Google Scholar
• Trowsdale J., Hanson I., Mockridge I., Beck S., Townsend A., Kelly A. Sequences encoded in the Class II region of the MHC related to the “ABC” superfamily of transporters. Nature 1990; 348: 741–743
   PubMed Web of Science ®Google Scholar
• Weaver J. L., Pine P. S., Aszalos A., et al. Laser scanning and confocal microscopy of daunorubicin, doxorubicin, and rhodamine 123 in multidrug-resistant cells. Exper. Cell Res. 1991; 196: 323–329
   PubMed Web of Science ®Google Scholar
• Gervasoni J. E., Fields S. Z., Krishna S., et al. Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy. Cancer Res. 1991; 51: 4955–4963
   PubMed Web of Science ®Google Scholar
• Robertson M. Proteasomes in the pathway. Nature 1991; 353: 300–301
   PubMed Web of Science ®Google Scholar
• Yanovitch S., Hall R. E., Weinert C. Resistance to natural killer cell-mediated cytolysis by a pleiotropic drug-resistant human erythroleukemia (K562-R) cell line. Cancer Res. 1986; 46: 4511–4515
   PubMed Web of Science ®Google Scholar
• Sharma R. C., Inoue S., Roitelman J., Schimke R. T., Simoni R. D. Peptide transport by the multidrug resistance pump. J. Biol. Chem. 1992; 267: 5731–5734
   PubMed Web of Science ®Google Scholar
• List A. F., Greer J. P., Azar C. A., et al. Circumvention of P-glycoprotein-mediated anthracycline resistance in acute myeloid leukemia with Cyclosporin-A. Blood 1991; 78(suppl 1)47A
   Google Scholar
• Kastan M. B., Schlatter E., Russo J. E., Colvin O. M., Civin C. I., Hilton J. Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic stem cells. Blood 1990; 75: 1947–1950
   PubMed Web of Science ®Google Scholar